24-hour ambulatory blood pressure monitoring and hypertension related risk among HIV-positive and HIV-negative individuals: Cross sectional study findings from rural Uganda.
暂无分享,去创建一个
M. Nyirenda | W. Checkley | Alex Kayongo | T. Siddharthan | R. Kalyesubula | F. Semitala | A. Wosu | Anxious J. Niwaha | Christabellah Namugenyi | A. Kayongo | A. Niwaha
[1] H. Tweya,et al. 24-H-AMBULATORY BLOOD PRESSURE MONITORING IN HIV(+) - INDIVIDUALS IN SUB-SAHARAN AFRICA , 2019, Journal of Hypertension.
[2] E. Valadas,et al. Cardiovascular risk in HIV-infected individuals: A comparison of three risk prediction algorithms. , 2019, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[3] M. Petersen,et al. Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study , 2019, BMC Public Health.
[4] P. Drain,et al. Integrating hypertension screening at the time of voluntary HIV testing among adults in South Africa , 2019, PloS one.
[5] G. Gottlieb,et al. Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015 , 2018, PloS one.
[6] Wondimye Ashenafi,et al. Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia , 2018, HIV/AIDS.
[7] G. Bloomfield,et al. Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms , 2018, Hypertension.
[8] W. Elmadhoun,et al. Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten , 2017, HIV/AIDS.
[9] Patrick A Ryscavage,et al. Prevalence of Systemic Hypertension Among HIV-Infected and HIV-Uninfected Young Adults , 2017, Open Forum Infectious Diseases.
[10] N. Levitt,et al. High prevalence of “non-dipping” blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals , 2017, PloS one.
[11] Xinguang Chen,et al. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. , 2017, Journal of the American Society of Hypertension : JASH.
[12] M. J. van der Laan,et al. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa , 2017, JAMA.
[13] L. Smeeth,et al. Ecological Study of HIV Infection and Hypertension in Sub-Saharan Africa: Is There a Double Burden of Disease? , 2016, PloS one.
[14] E. Mills,et al. Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, Uganda: a retrospective study , 2016, BMJ Global Health.
[15] Ashutosh Kumar Singh,et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.
[16] O. Uthman,et al. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis , 2016, Journal of Human Hypertension.
[17] M. Petersen,et al. Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda , 2016, PloS one.
[18] S. Oparil,et al. Ambulatory Blood Pressure Monitoring in Individuals with HIV: A Systematic Review and Meta-Analysis , 2016, PloS one.
[19] R. Walker,et al. Ambulatory Blood Pressure Monitoring to Assess the White‐Coat Effect in an Elderly East African Population , 2015, Journal of clinical hypertension.
[20] Evelyn P Whitlock,et al. Diagnostic and Predictive Accuracy of Blood Pressure Screening Methods With Consideration of Rescreening Intervals: A Systematic Review for the U.S. Preventive Services Task Force , 2015, Annals of Internal Medicine.
[21] Geoffrey A Head,et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. , 2014, Journal of hypertension.
[22] N. Levitt,et al. Ambulatory blood pressure profiles in a subset of HIV-positive patients pre and post antiretroviral therapy , 2014, Cardiovascular journal of Africa.
[23] L. Smeeth,et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis , 2013, International journal of epidemiology.
[24] V. Triant. Cardiovascular Disease and HIV Infection , 2013, Current HIV/AIDS Reports.
[25] K. Kraemer,et al. HIV infection and the risk of acute myocardial infarction. , 2013, JAMA internal medicine.
[26] G. Pucci,et al. Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study , 2013, Journal of hypertension.
[27] T. Bärnighausen,et al. Hypertension and Obesity in Adults Living in a High HIV Prevalence Rural Area in South Africa , 2012, PloS one.
[28] Jianyun Wu,et al. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta‐analysis , 2012, HIV medicine.
[29] C. Tremblay,et al. Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québec's Public Health Insurance Database , 2011, Journal of acquired immune deficiency syndromes.
[30] P. Tebas,et al. Aging and HIV Infection: A Comparison Between Older HIV-Infected Persons and the General Population , 2010, HIV clinical trials.
[31] Anne L. Taylor,et al. Coronary heart disease in HIV-infected individuals. , 2003, Journal of acquired immune deficiency syndromes.
[32] HIV and AIDS in East and Southern Africa regional overview , 2018 .
[33] W. Elliott,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2008 .
[34] W. El-Sadr,et al. Can the Success of Hiv Scale-up Advance the Global Chronic Ncd Agenda? Differing Global Responses to Hiv and Ncd , 2022 .